Eli Lilly (Suisse) S.A. Eesti Affiliate
A.H.Tammsaare tee 47
11316 Tallinn, Estonia
Tel. +372 6817280
Eli Lilly and Company is a leading innovation-driven pharmaceutical corporation with headquarters in Indianapolis. By applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations, it creates and delivers medicines that enable people to live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, diabetes, cancer, osteoporosis and many other diseases. They create value for patients, healthcare providers and payers, and reduce the cost of disease. Its best known trademarks are Prozac, Zyprexa, Evista and Humalog. The company employs more than 42,000 people worldwide and markets its medicines in 143 countries. Eli Lilly started its operations in Estonia in 1993 . By now it has brought to the Estonian market a wide and still growing portfolio of best-in-class pharmaceutical products. Estonia was one of the first countries in the world in which Lilly launched Humalog Mix, insulin that is now used by millions of patients worldwide. As our company touches the lives of people across the globe, we recognize that we have a responsibility for being good corporate citizens in our communities and helping to preserve the environment for the generations to come.